101 – 200 of 247
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
COMP a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker
(
- Contribution to journal › Article
-
Mark
Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register.
(
- Contribution to journal › Article
-
Mark
The Swedish biologics register (ARTIS): observations of adverse events when using biologics in clinical practice
(
- Contribution to journal › Published meeting abstract
-
Mark
Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register.
(
- Contribution to journal › Article
-
Mark
Health utilities improvement during TNF blockade in chronic arthritis occurs early in the treatment course, results from an eight year observational study in southern Sweden
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.552-552(
- Contribution to journal › Published meeting abstract
-
Mark
Citrullinated proteins are present in synovial fluids from inflammatory arthritis but not osteoarthritis
(
- Contribution to journal › Published meeting abstract
-
Mark
Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis
(
- Contribution to journal › Article
- 2007
-
Mark
The impact of IL-1Ra and MBL gene polymorphisms on joint damage after 5 and 10 years in patients with early rheumatoid arthritis
(
- Contribution to journal › Letter
-
Mark
The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review.
(
- Contribution to journal › Article
-
Mark
Research in hand osteoarthritis: time for reappraisal and demand for new strategies. An opinion paper
(
- Contribution to journal › Scientific review
-
Mark
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists
(
- Contribution to journal › Article
-
Mark
Behandling af reumatoid artrit med anti-tumornekrosefaktor-alpha-antistof. Individuel monitorering af biotilgaengelighed og immunogenicitet-- sekundaerpublikation
(
- Contribution to journal › Article
-
Mark
Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies
(
- Contribution to journal › Article
-
Mark
Treatment with TNF-blockers and mortality risk in patients with rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.
(
- Contribution to journal › Article
-
Mark
Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab
(
- Contribution to journal › Letter
-
Mark
Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials
(
- Contribution to journal › Article
-
Mark
Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers
(
- Contribution to journal › Article
- 2006
-
Mark
Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab
(
- Contribution to journal › Article
-
Mark
Predictors of infusion reactions during infliximab treatment in patients with arthritis.
(
- Contribution to journal › Article
-
Mark
Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden
(
- Contribution to journal › Article
-
Mark
The LUNDEX, a new index of drug efficacy in clinical practice: results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Anti-inflammatory effects of contralateral administration of the kappa-opioid agonist U-50,488H in rats with unilaterally induced adjuvant arthritis
(
- Contribution to journal › Article
-
Mark
Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Allvarlig lungsjukdom vid RA och TNF-blockering--finns det ett samband?
(
- Contribution to journal › Article
-
Mark
Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Serum levels of Cartilage Oligomeric Matrix Protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis
(
- Contribution to journal › Article
-
Mark
Non-collagenous Proteins; Glycoproteins and related proteins
2006) p.71-84(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Biomarkers for cartilage and bone in rheumatoid arthritis
2006) p.301-301(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Noncollagenous Proteins: Glycoproteins and Related Proteins
2006) p.71-84(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Glukosamin hjälper inte mot smärta vid knäartros
(
- Contribution to journal › Letter
-
Mark
Classification of osteoarthritis biomarkers: a proposed approach
(
- Contribution to journal › Scientific review
-
Mark
The heritable determinants of cartilage oligomeric matrix protein
(
- Contribution to journal › Article
- 2005
-
Mark
Prediction of mortality in rheumatoid arthritis based on disease activity markers.
(
- Contribution to journal › Article
-
Mark
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
(
- Contribution to journal › Article
-
Mark
Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Changes of cartilage and bone markers after intraarticular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
No increase of severe infections in RA patients treated with TNF-blockers
2005) Annual European Congress of Rheumatology, 2005 In Annals of the Rheumatic Diseases 64(Suppl. 3). p.461-462(
- Contribution to journal › Published meeting abstract
-
Mark
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept
(
- Contribution to journal › Article
-
Mark
Prognostic laboratory markers of joint damage in rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Population based studies of biological antirheumatic drug use in southern Sweden: comparison with pharmaceutical sales
(
- Contribution to journal › Letter
-
Mark
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
(
- Contribution to journal › Article
-
Mark
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
(
- Contribution to journal › Article
-
Mark
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
(
- Contribution to journal › Article
-
Mark
CNI-1493, an inhibitor of proinflammatory cytokines, retards cartilage destruction in rats with collagen induced arthritis
(
- Contribution to journal › Article
-
Mark
Matrix Glycoproteins and Proteoglycans in Cartilage
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Response criteria for rheumatoid arthritis in clinical practice - how useful are they?
(
- Contribution to journal › Article
- 2004
-
Mark
Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor alpha blockade: comment on the article by Buch et al
(
- Contribution to journal › Letter
-
Mark
Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP
(
- Contribution to journal › Article
-
Mark
Hormone replacement therapy, calcium and vitamin D-3 versus calcium and vitamin D-3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]
(
- Contribution to journal › Article
-
Mark
Fibronectin fragments cause release and degradation of collagen-binding molecules from equine explant cultures.
(
- Contribution to journal › Article
- 2003
-
Mark
Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Recent developments and future research in the bone and joint decade 2000-2010.
(
- Contribution to journal › Letter
-
Mark
Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis.
(
- Contribution to journal › Article
-
Mark
Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Inflammation is a feature of the disease process in early knee joint osteoarthritis.
(
- Contribution to journal › Letter
-
Mark
Cyclosporin A in rheumatoid arthritis
(
- Contribution to journal › Letter
-
Mark
Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept.
(
- Contribution to journal › Article
- 2002
-
Mark
Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation.
(
- Contribution to journal › Article
-
Mark
Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Förlegat beskriva artros som "degenerativ ledsjukdom"
(
- Contribution to journal › Letter
-
Mark
Increased serum cartilage oligomeric matrix protein levels and decreased patellar bone mineral density in patients with chondromalacia patellae.
(
- Contribution to journal › Article
-
Mark
Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats.
(
- Contribution to journal › Article
-
Mark
Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage.
(
- Contribution to journal › Article
-
Mark
Behandling med TNF-hämmare vid reumatoid artrit
(
- Contribution to journal › Article
-
Mark
Markers of joint tissue turnover in osteoarthritis
2002) p.285-292(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Markers of joint tissue turnover in osteoarthritis
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2001
-
Mark
Association of chondroadherin with collagen type II
(
- Contribution to journal › Article
-
Mark
Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Cytokines, metalloproteinase, their inhibitors, and COMP: relation to radiological progression and inflammation in early rheumatoid arthritis
(
- Contribution to journal › Article
- 2000
-
Mark
Clinical protocol for monitoring of targeted therapies in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Genetic control of arthritis in rats
(
- Contribution to journal › Article
-
Mark
Diagnosis of osteoarthritis in relation to molecular processes in cartilage: comment on the article by Clark et al.
(
- Contribution to journal › Article
-
Mark
Molecular markers for assessment of cartilage damage in rheumatoid arthritis
2000) p.291-304(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis
(
- Contribution to journal › Article
-
Mark
Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relations to pulmonary involvement
(
- Contribution to journal › Article
-
Mark
Matrix Glycoproteins and Proteoglycans in Cartilage
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Nya läkemedel mot reumatoid artrit : Förbättrade behandlingsmöjligheter ställer nya krav på sjukvårdsorganisationen
(
- Contribution to journal › Article
- 1999
-
Mark
Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with osteoarthritis-related type II collagen gene COL2A1 mutation
(
- Contribution to journal › Article
-
Mark
Synergistic protection against cartilage destruction by low dose prednisolone and interleukin-10 in established murine collagen arthritis
(
- Contribution to journal › Article
-
Mark
Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978
(
- Contribution to journal › Article
-
Mark
IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
(
- Contribution to journal › Article
-
Mark
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis
(
- Contribution to journal › Article
- 1998
-
Mark
Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint
(
- Contribution to journal › Article
-
Mark
Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis
(
- Contribution to journal › Article
-
Mark
Joint space width in the axial view of the patello-femoral joint: Definitions and comparisons with MR imaging
(
- Contribution to journal › Article
-
Mark
Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats
(
- Contribution to journal › Article
-
Mark
Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: A one year prospective study.
(
- Contribution to journal › Article
-
Mark
Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats
(
- Contribution to journal › Article
- 1997
-
Mark
Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis: relation to development of knee or hip joint destruction
(
- Contribution to journal › Article
-
Mark
Cartilage markers in synovial fluid in symptomatic knee osteoarthritis
(
- Contribution to journal › Article
-
Mark
Serum biological markers as predictors of disease progression in osteoarthritis of the knee
(
- Contribution to journal › Letter
-
Mark
HLA DRB1* typing and cartilage oligomeric matrix protein as predictors of joint destruction in recent onset rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Radiographic osteoarthritis of the knee classified by the Ahlbäck and Kellgren & Lawrence systems for the tibiofemoral joint in people aged 35–54 years with chronic knee pain.
(
- Contribution to journal › Article
-
Mark
Cartilage matrix macromolecules in joint fluid of temporomandibular joints before and six months after diskectomy
(
- Contribution to journal › Article
-
Mark
Cartilage macromolecules and the development of new methods for the assessment of joint disease
(
- Contribution to journal › Article
-
Mark
Serum analyses of tissue derived macromolecules and markers of inflammation in early rheumatoid arthritis. Relation to development of joint destructions in hands and feet
(
- Contribution to journal › Article
-
Mark
Postero-anterior radiogram of the knee in weightbearing and semiflexion. Comparison with MR imaging
(
- Contribution to journal › Article
-
Mark
Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis
(
- Contribution to journal › Article
-
Mark
Cartilage macromolecules in knee synovial fluid. Markers of the disease course in patients with acute oligoarthritis
(
- Contribution to journal › Article